Stanley Hostler - Protea Biosciences Insider

PRGB -- USA Stock  

USD 0.035  0.00  0.00%

  Director
Mr. Stanley Hostler is Vice President, Secretary, Director of the Company. He was a Director of the Company since January 2006 and Vice President and Secretary since June 2006. Mr. Hostler is an attorney with a career practice in the field of labor and employment law. From 2000 to 2010 he served as Special Assistant to the Governor of the State of West Virginia. From 2002 to 2004 he served as Counsel to the Prim Law Firm. From 2000 to 2010 he served on the West Virginia University Foundation Board of Directors, and from 1995 to 2010 on the Advisory Committee of the WVU School of Medicine. He is a Graduate of the West Virginia University School of Law . Mr. Hostlers legal experience and business contacts and relationships with West Virginia University and the State of West Virginia have been an asset to the Company and led the board to determine that he should serve as a director of the Company.
Age: 86        
304-292-2226  http://www.proteabio.com

Stanley Hostler Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (104.33) % which means that it has lost $104.33 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (31.9) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 10.93 M in liabilities. Protea Biosciences Group has Current Ratio of 0.04 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Thomas RantzauNovo Nordisk AS
2018
Gayle WilsonGilead Sciences
2001
Julia HallerCelgene Corporation
2015
Maurice RenshawCSL Limited
2004
Ian ClarkShire plc
2017
Richard MeierBioMarin Pharmaceutical
2015
Stig StroebaekNovo Nordisk AS
1998
Olivier BohuonShire plc
2018
Robert EckertAmgen
2016
Francois CarbonnelAmgen
2008
Jeffrey PoultonShire plc
2015
John AkehurstCSL Limited
2004
Gregory GarlandAmgen
2013
Bryan LawlisBioMarin Pharmaceutical
2007
Willard DereBioMarin Pharmaceutical
2016
Steven GillisShire plc
2012
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Christine OReillyCSL Limited
2011
Ellen KullmanAmgen
2017
Bruno AngeliciNovo Nordisk AS
2011
Anthony ColesRegeneron Pharmaceuticals
2017

Entity Summary

Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. Protea Biosciences Group (PRGB) is traded on OTC Market in USA. It is located in Protea Biosciences Group, IncMorgantown, WV and employs 35 people.

Protea Biosciences Leadership Team

Leonard Harris, Independent Director
Stephen Turner, Chairman, CEO and Pres
Gregory Kilby, COO and VP of Operations
Edwin Roberson, Independent Director
Stanley Hostler, VP, Secretary, Director and Member of Audit Committee
Steven Antoline, Independent Director
Edward Hughes, CFO
Scott Segal, Independent Director
Ed Roberson, Independent Director
Patrick Gallagher, Director
Andrew Zulauf, Independent Director
Josiah Austin, Independent Director
Matthew Powell, Chief Science Officer and VP of RandD
David Halverson, Vice President Chief Business Officer
Maged Shenouda, Director

Stock Performance Indicators

Current Sentiment - PRGB

Protea Biosciences Investor Sentiment

Most of Macroaxis users are at this time bullish on Protea Biosciences Group. What is your perspective on investing in Protea Biosciences Group? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
CRM   
Purchased a lot of shares of
few days ago
Traded for 156.0
CRM   
Purchased a lot of shares of
few days ago
Traded for 156.0
F   
Purchased over 300 shares of
few days ago
Traded for 9.81
C   
Purchased over 40 shares of
few days ago
Traded for 74.735
GM   
Purchased over 70 shares of
few days ago
Traded for 36.08
Additionally take a look at Your Equity Center. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com